Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Rajesh Agarwal of Eastern Financiers suggests buying Mahindra Ugine Steel Company, IVRCL, Lakshmi Vilas Bank and Alembic Pharmaceuticals.
Rajesh Agarwal of Eastern Financiers advised buying Mahindra Ugine for a target price of Rs 93 and IVRCL for a price target of Rs 17.50.
SP Tulsian, sptulsian.com advises traders to avoid Alembic Pharma at current levels.
In CNBC-TV18's popular show Bull's Eye, Rajesh Agarwal, Eastern Financiers shares trading strategy of the day.
SP Tulsian of sptulsian.com advised buying Alembic Pharma at around Rs 82-84. He expects the stock to hit these levels in a week.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Alembic Pharma has target of Rs 100, says SP Tulsian, sptulsian.com
It was a volatile day on the Dalal Street as the markets turned around in late trade. Indices closed flat after a weak start. The Nifty closed just shy of 5,900 and the Sensex ended at 19,468.
Tata Motors and M&M are top picks in auto space, says Nitin Raheja, CIO, AQF Advisors.
In CNBC-TV18's popular show Bull's Eye, Sharmila Joshi, Fairwealth Securities shares trading strategy of the day.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Market expert SP Tulsian, sptulsian.com picked pharma company Alembic and EPC player Techno Electric as his multibagger stocks. He expects these stocks to fetch better returns ahead.
Alembic Pharmaceuticals can touch Rs 75 in next six months, says SP Tulsian, sptulsian.com. I am quite bullish on FY14 going forward because by then they should be able to take their topline close to about Rs 2,000 crore with EPS of close to about Rs 10.
In CNBC-TV18's popular show Bull's Eye, SP Tulsian, sptulsian.com shares trading strategy of the day.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Alembic Pharmaceuticals has target of Rs 80, says PN Vijay, Portfolio Manager.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.